A multidomain, nurse-led, mobile health-supported intervention for dementia risk reduction in primary care (HAPPI MIND): a pragmatic, single-blind, two-arm, cluster randomised controlled trial
Authors:
- Muhammad Rehan SarwarMSMuhammad Rehan Sarwar
- Kali GodbeeKGKali Godbee
- Amanda J. CrossACAmanda J. Cross
- Gopisankar Mohanannair GeethadeviGGGopisankar Mohanannair Geethadevi
- Parker MaginPMParker Magin
- Amanda L. BakerABAmanda L. Baker
- Billie BonevskiBBBillie Bonevski
- Sharleen L. O'REillySOSharleen L. O'REilly
- Marlien VarnfieldMVMarlien Varnfield
- Rajiv JayasenaRJRajiv Jayasena
- Stephanie A. WardSWStephanie A. Ward
- Ajay MahalAMAjay Mahal
Open Access
- 20 October 2026
- journal article
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 75
Abstract
No abstract availableFunding Information
- National Health and Medical Research Council (GNT1171851)
This publication has 24 references indexed in Scilit:
- Identifying dementia risk profiles for targeted interventions: A latent class analysis of at‐risk middle‐aged AustraliansAlzheimer's & Dementia, 2025
- Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive FunctionJAMA, 2025
- A systematic review of targeted dementia risk reduction interventions in middle-aged adults in Primary CareThe Journal Of Prevention of Alzheimer's Disease, 2025
- Dementia prevention, intervention, and care: 2024 report of the Lancet standing CommissionThe Lancet, 2024
- Validated Alzheimer’s Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60sBrain Imaging and Behavior, 2017
- Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) CohortJAMA Neurology, 2017
- MIND diet slows cognitive decline with agingAlzheimer's & Dementia, 2015
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trialThe Lancet, 2015
- Development of a New Method for Assessing Global Risk of Alzheimer’s Disease for Use in Population Health Approaches to PreventionPrevention Science, 2013
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011